Artivion Q1 revenue slightly beats, cuts 2026 outlook

Artivion

07/05/2026 21:43

Overview

US cardiac device maker's Q1 revenue rose 18%, slightly beating analyst expectations

Adjusted EPS for Q1 was $0.08, beating analyst expectations

Company lowered 2026 revenue and adjusted EBITDA guidance

Outlook

Artivion lowers 2026 revenue outlook to $480 mln-$496 mln from $486 mln-$504 mln

Company now sees 2026 adjusted EBITDA at $100 mln-$107 mln, down from $105 mln-$110 mln

U.S. revenue from NEXUS product sales expected to be negligible in 2026 ahead of 2027 launch

Result Drivers

PRODUCT GROWTH - Revenue gains driven by stent grafts, On-X , and preservation services, per CEO Pat Mackin

MARKET SHARE GAINS - On-X continued to take share from mechanical and bioprosthetic valves, per CEO

TRANSIENT FACTORS - Q1 performance fell short of constant currency expectations due to some transient factors, according to management

Company press release: ID:nPnbh4fKGa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Slight Beat*
$116.33 mln
$115.80 mln (8 Analysts)
Q1 Adjusted EPS
Beat
$0.08
$0.05 (8 Analysts)
Q1 Adjusted Net Income
Beat
$4.17 mln
$2.27 mln (7 Analysts)
Q1 Net Income
$1.42 mln
Q1 EBIT
$5.78 mln
Q1 Operating Expenses
$69.66 mln
Q1 Pretax Profit
$339,000


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Artivion Inc is $51.50, about 48.3% above its May 6 closing price of $34.73

The stock recently traded at 63 times the next 12-month earnings vs. a P/E of 90 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)